You are here

CP-690,550 And Oral Contraception Drug-Drug Interaction Study

Last updated on February 17, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Bruxelles, , B-1070 Belgium
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Healthy
Sex
Female
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-55 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Healthy female subjects

- No evidence of active or latent or inadequately treated infection with Mycobacterium
tuberculosis

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Any medical reason which would contraindicate the administration of oral
contraceptives

- Clinically significant infections within the past 3 months or history of febrile
illness within 5 days

- Positive screening test for Hepatitis B surface antigen, anti Hepatitis C antibody, or
human immunodeficiency virus

- Pregnant or nursing women, and women of childbearing potential who are unwilling or
unable to use an acceptable method of nonhormonal contraception

NCT01137708
Pfizer
Completed
CP-690,550 And Oral Contraception Drug-Drug Interaction Study

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now